Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors | Patent Number 11793749

US 11793749 B2

Application Number17407419

Publication NumberUS 20220110861 A1

Pendency2 years, 2 months, 5 days

Filled DateAug 20, 2021

Priority DateDec 18, 2014

Publication DateApr 14, 2022

Expiration DateDec 17, 2034

Inventor/ApplicantsChris Ho
Michael Santos
Donglai Yang
C. Michael Philbrook
Harvey Lieberman

ExaminesHUI, SAN MING R

Art Unit1627

Technology Center1600

Assignments

Law Firm

You must be logged in to view

Attorneys

Subscription-Only

See the invalidated claims, subscribe to our Concierge Program.

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.